Annual Drug Patent Expirations for VELCADE
Velcade is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for VELCADE.
The generic ingredient in VELCADE is bortezomib. One supplier is listed for this compound. Additional details are available on the bortezomib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
